Medicine and Dentistry
Catheter Ablation
100%
Atrial Fibrillation
90%
Catheter Ablation
88%
Persistent Atrial Fibrillation
69%
Ventricular Tachycardia
27%
Tachyarrhythmia
24%
Supraventricular Tachycardia
21%
Radiofrequency Ablation
20%
Pulmonary Vein Isolation
18%
Recurrent Disease
18%
Meta-Analysis
15%
Atrial Fibrillation Ablation
13%
Endocardium
13%
Paroxysmal Atrial Fibrillation
11%
Rheumatic Heart Disease
11%
Pulmonary Vein
10%
Transesophageal Echocardiography
9%
Ablation Therapy
9%
Heart Left Ventricle Ejection Fraction
8%
Rhythm
8%
Mitral Insufficiency
7%
Arrhythmogenic Right Ventricular Dysplasia
7%
Randomized Clinical Trial
7%
Prevalence
7%
Wolff-Parkinson-White Syndrome
7%
Dilated Cardiomyopathy
7%
T Wave Inversion
7%
Infection
7%
Direct Oral Anticoagulant
7%
Clinical Trial
7%
Sinus Bradycardia
7%
Surgical Ablation
7%
COVID-19
7%
Inferior Vena Cava
7%
Superior Vena Cava
7%
Heart Left Ventricle Function
7%
Antithrombotic Therapy
7%
Valve Replacement
7%
Ischemic Cardiomyopathy
7%
Situs Inversus
7%
Premature Ventricular Contraction
7%
Elderly Patient
7%
Fluoroscopy
7%
Systematic Review
7%
Electrophysiology
7%
Autonomic Denervation
7%
Atrial Electrogram
6%
Puncture
6%
Right Atrium
6%
Randomized Controlled Trial
5%
Keyphrases
Catheter Ablation
56%
Persistent Atrial Fibrillation
45%
Ventricular Tachycardia
30%
Atrial Fibrillation Ablation
23%
Ablation
21%
Ventricular Tachycardia Ablation
14%
Ischemic Cardiomyopathy
14%
Atrial Fibrillation
13%
Epicardial Ablation
12%
Confidence Interval
10%
Atrial Fibrillation Recurrence
9%
Transesophageal Echocardiography
9%
Clinical Outcomes
8%
Atrial Tachycardia
8%
Atrial Fibrillation Duration
7%
Procedural Complications
7%
Radiofrequency Ablation
7%
Ventricular Model
7%
Meta-analysis
7%
Subcutaneous Implantable Cardioverter-defibrillator (S-ICD)
7%
Endocardial Ablation
7%
Multicenter Registry
7%
General Anesthesia
7%
Vasovagal Reaction
7%
Randomized Clinical Trial
7%
Electrophysiology Procedures
7%
Interrupted Inferior Vena Cava
7%
Situs Inversus Totalis
7%
Algorithm Integration
7%
Rhythm Control
7%
Atrial Imaging
7%
Age Impact
7%
Ablation Complication
7%
Symptomatic Sinus Bradycardia
7%
Vein of Marshall
7%
Long-term Clinical Outcome
7%
Left Ventricular Ejection Fraction
7%
Amiodarone
7%
Superior Vena Cava
7%
Swine Heart
7%
Access Site Complications
7%
Pre-excited Atrial Fibrillation
7%
Left Ventricular Function
7%
Tumescent Anesthesia
7%
Recurring
7%
Fluoroless
7%
Systematic Meta-analysis
7%
Cardioverter-defibrillator Implantation
7%
Direct Oral Anticoagulants
7%
Epicardial Access
7%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
73%
Persistent Atrial Fibrillation
60%
Tachycardia
28%
Recurrent Disease
22%
Heart Ventricle Tachycardia
14%
Ischemic Cardiomyopathy
14%
Rheumatic Heart Disease
12%
Heart Arrhythmia
11%
Supraventricular Tachycardia
11%
Clinical Trial
10%
Mitral Valve Regurgitation
7%
Paroxysmal Atrial Fibrillation
7%
Congestive Cardiomyopathy
7%
Sinus Bradycardia
7%
Amiodarone
7%
Pig
7%
Troponin
7%
Infection
7%
Wolff Parkinson White Syndrome
7%
Symptom
6%
Randomized Controlled Trial
5%